SPRINT Sprint Bioscience AB (publ)

3.460SEK-3.35%Mkt Cap: 34.92M $P/E: 4.94

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by…